-
Sword Group | Q2 2026 Results
Consolidated Revenue: €97.0mOrganic Growth (i): +13.7%Profitability (EBITDA Margin): 12.0%(i) on a like-for-like basis and at constant exchange rates KEY FIGURESThe consolidated revenue for the second quarter of 2026 amounted to €97.0 million, representing an increase of 13.7% at constant scope and exchange rates compared with the second quarter of 2025.Profitability (EBITDA margin) reached 12.0%, corresponding…
-
Espire Hospitality Announces Results for FY 2026 and Q4-FY26
Espire Hospitality Limited reports its highest ever revenue of ₹14,106 Lakhs in FY 2026, a growth of 17% as compared to FY 2025; and its highest ever EBITDA of ₹3,190 Lakhs, a growth of 38% as compared to FY 2025 The Company has registered a revenue of ₹4,873 Lakhs in Q4-FY26, a growth of 19% as…
-
Akums Reports Q2 FY26 Results; Strengthens International Presence
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26. The CDMO segment remained the key contributor with revenue of Rs. 804 crore. Volumes for the CDMO vertical grew 7% y-o-y, as against muted industry volume growth, reflecting…
-
Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Dividend
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), announced its financial results for the fourth quarter and the full year ended March 31, 2026. The company delivered a steady performance during Q4 FY26, with healthy revenue growth and improved operating profitability driven by its core domestic…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.